{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:02:16Z","timestamp":1790758936594,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T00:00:00Z","timestamp":1395014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090159","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T16:31:57Z","timestamp":1395073917000},"page":"e90159","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma"],"prefix":"10.1371","volume":"9","author":[{"given":"Hsiao-Chi","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(10)70062-0","article-title":"Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects","volume":"11","author":"KA Janeway","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1245\/ASO.2003.03.061","article-title":"Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity","volume":"10","author":"RM Wilkins","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/mp.56.2.127","article-title":"Proposal for a unified CCN nomenclature","volume":"56","author":"DR Brigstock","year":"2003","journal-title":"Molecular pathology: MP"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","article-title":"CCN proteins: multifunctional signalling regulators","volume":"363","author":"B Perbal","year":"2004","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1371\/journal.pone.0000534","article-title":"Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer","volume":"2","author":"PP Chen","year":"2007","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.onc.1202395","article-title":"Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells","volume":"18","author":"C Wenger","year":"1999","journal-title":"Oncogene"},{"key":"ref7","first-page":"8917","article-title":"Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features","volume":"61","author":"D Xie","year":"2001","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2008.09.021","article-title":"Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13","volume":"44","author":"CH Hou","year":"2009","journal-title":"Bone"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2133.1998.02354.x","article-title":"Expression of fibrogenic cytokines in desmoplastic malignant melanoma","volume":"139","author":"M Kubo","year":"1998","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/bjc.2011.226","article-title":"CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration","volume":"105","author":"S Braig","year":"2011","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ijc.25257","article-title":"Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme","volume":"127","author":"D Yin","year":"2010","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.24188","article-title":"Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype","volume":"124","author":"KL Sodek","year":"2009","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G","article-title":"Expression of connective tissue growth factor in cartilaginous tumors","volume":"89","author":"T Shakunaga","year":"2000","journal-title":"Cancer"},{"key":"ref14","first-page":"795","article-title":"The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis","volume":"25","author":"GW Zuo","year":"2010","journal-title":"Histol Histopathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0079-6107(98)00052-2","article-title":"Signaling through focal adhesion kinase","volume":"71","author":"DD Schlaepfer","year":"1999","journal-title":"Prog Biophys Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jcb.22131","article-title":"Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK\/Erk and\/or PI3-K\/Akt-1","volume":"107","author":"MJ Demers","year":"2009","journal-title":"Journal of cellular biochemistry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"JA McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1535-7163.MCT-04-0297","article-title":"Raf kinase as a target for anticancer therapeutics","volume":"4","author":"SS Sridhar","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","article-title":"Survivin, versatile modulation of cell division and apoptosis in cancer","volume":"22","author":"DC Altieri","year":"2003","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2006.03.007","article-title":"Structural, functional and therapeutic biology of survivin","volume":"244","author":"NK Sah","year":"2006","journal-title":"Cancer Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","article-title":"HMGB1 promotes drug resistance in osteosarcoma","volume":"72","author":"J Huang","year":"2012","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.4049\/jimmunol.0802826","article-title":"Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1- dependent pathway","volume":"183","author":"YC Chiu","year":"2009","journal-title":"J Immunol"},{"key":"ref23","first-page":"3235","article-title":"Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line","volume":"27","author":"M Yatomi","year":"2007","journal-title":"Anticancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ejca.2011.05.030","article-title":"Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand","volume":"47","author":"JK Anninga","year":"2011","journal-title":"European journal of cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/156800909788166600","article-title":"Overcoming drug resistance by enhancing apoptosis of tumor cells","volume":"9","author":"P Gimenez-Bonafe","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"ref26","first-page":"3976","article-title":"Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis","volume":"53","author":"SH Kaufmann","year":"1993","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity","volume":"7","author":"V Cepeda","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jso.20507","article-title":"Expression of survivin and correlation with PCNA in osteosarcoma","volume":"93","author":"W Wang","year":"2006","journal-title":"J Surg Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1267\/ahc.06005","article-title":"Survivin as a prognostic factor for osteosarcoma patients","volume":"39","author":"E Osaka","year":"2006","journal-title":"Acta Histochem Cytochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/ejso.2002.1415","article-title":"Survivin expression in human osteosarcoma is a marker for survival","volume":"29","author":"K Trieb","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cellbi.2008.10.013","article-title":"Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro","volume":"33","author":"X Liang","year":"2009","journal-title":"Cell Biol Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biomed.2011.10.001","article-title":"Implication of nuclear EGFR in the development of resistance to anticancer therapies","volume":"1","author":"WC Huang","year":"2011","journal-title":"BioMedicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/0008-5472.CAN-3502-02","article-title":"Inhibition of connective tissue growth factor (CTGF\/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells","volume":"64","author":"S Croci","year":"2004","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/jnci\/djh059","article-title":"Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis","volume":"96","author":"CC Chang","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3835(02)00718-8","article-title":"Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line","volume":"192","author":"NH Moritani","year":"2003","journal-title":"Cancer Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-3-5","article-title":"Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation","volume":"3","author":"N Schutze","year":"2005","journal-title":"Cell Commun Signal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.gastro.2004.10.007","article-title":"Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer","volume":"128","author":"BR Lin","year":"2005","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-08-2524","article-title":"Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1","volume":"69","author":"MY Wang","year":"2009","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"L Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bone.2010.05.027","article-title":"Functional and biological analysis of Bcl-xL expression in human osteosarcoma","volume":"47","author":"ZX Wang","year":"2010","journal-title":"Bone"},{"key":"ref41","first-page":"237","article-title":"Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study","volume":"43","author":"B Karczmarek-Borowska","year":"2005","journal-title":"Folia Histochem Cytobiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1368-7646(02)00049-3","article-title":"Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions","volume":"5","author":"N Zaffaroni","year":"2002","journal-title":"Drug Resist Updat"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i1.40","article-title":"The role of connective tissue growth factor (CTGF\/CCN2) in skeletogenesis","volume":"21","author":"JA Arnott","year":"2011","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jcp.24124","article-title":"Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway","volume":"228","author":"A Spina","year":"2013","journal-title":"J Cell Physiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:04:48Z","timestamp":1540332288000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090159"}},"subtitle":[],"editor":[{"given":"Philip C.","family":"Trackman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090159","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,17]]}}}